Newsletter | July 15, 2026

What Operation TrialBlazer Gets Right — And Where It Stalls

DECENTRALIZED TRIALS

Trends In Rare Disease Trials: Recommendations

In the third article of this series, analyst reveal their top 6 recommendations for designing selection criteria and selecting solution options to optimize rare disease research outcomes.

Why We Need To Look To The Future Of Clinical Trials

Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

Leveraging Mobile Vision Clinics For Clinical Trial Exams

Are you considering new options to improve your patient experience and expand your clinical trial's reach? Explore how a mobile vision clinic is providing a full optometry suite for all types of clinical trials.

TRIAL MANAGEMENT

Beyond The IND Clock: What Operation TrialBlazer Gets Right — And Where It Stalls (Part 1)

The FDA's Operation TrailBlazer includes a proposal to speed up IND review and approval. But will it work? Kimberly Chew and Odette Hauke identify where the initiative succeeds and where the structural gaps begin.

Global Trials, Zero Delays: Rethinking Clinical Logistics

This comprehensive guide provides practical insights and best practices for ensuring the timely, secure, and reliable delivery of clinical trial materials worldwide.

Early-Phase Trials: From Data Generation To Decision Support

Early clinical research is shifting to decision-focused designs, using biomarkers, functional endpoints, and targeted populations to reduce uncertainty and enable clearer progression.

Biomarkers In Hematology: The Engine Behind Precision Oncology

Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.

Accelerating Clinical Supply Through Integrated Drug Development

See how parallel processing integrates clinical supply into drug development, enabling simultaneous workstreams that address packaging, labeling, and sourcing challenges.

Why Central IRBs Matter For Efficient Clinical Trials

Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: